What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Stroke
- Surgery
His primary areas of study are Stroke, Internal medicine, Fibrinolytic agent, Cardiology and Perfusion scanning.
His research integrates issues of Randomized controlled trial, Surgery and Magnetic resonance imaging in his study of Stroke.
His study in Surgery is interdisciplinary in nature, drawing from both Clinical trial and Desmoteplase.
His studies deal with areas such as Emergency medical services, Emergency department, Placebo, Modified Rankin Scale and Tissue plasminogen activator as well as Fibrinolytic agent.
In his research, Severity of illness and Stroke recovery is intimately related to Logistic regression, which falls under the overarching field of Cardiology.
His work investigates the relationship between Perfusion scanning and topics such as Penumbra that intersect with problems in Infarction and Pathology.
His most cited work include:
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials (1186 citations)
- Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. (865 citations)
- Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage (802 citations)
What are the main themes of his work throughout his whole career to date?
Mark W. Parsons mainly focuses on Stroke, Internal medicine, Thrombolysis, Cardiology and Perfusion scanning.
His Stroke research integrates issues from Radiology, Perfusion and Surgery.
His work on Brain ischemia, Modified Rankin Scale, Cerebral infarction and Clinical trial as part of general Internal medicine study is frequently linked to Clinical neurology, bridging the gap between disciplines.
His Thrombolysis research incorporates themes from Randomized controlled trial, Emergency medicine, Magnetic resonance imaging, Tissue plasminogen activator and Acute stroke.
His Cardiology study combines topics from a wide range of disciplines, such as Prospective cohort study and Acute ischemic stroke, Ischemic stroke.
The various areas that Mark W. Parsons examines in his Perfusion scanning study include Cerebral blood flow and Receiver operating characteristic.
He most often published in these fields:
- Stroke (80.27%)
- Internal medicine (41.95%)
- Thrombolysis (39.27%)
What were the highlights of his more recent work (between 2019-2021)?
- Stroke (80.27%)
- Internal medicine (41.95%)
- Thrombolysis (39.27%)
In recent papers he was focusing on the following fields of study:
Stroke, Internal medicine, Thrombolysis, Cardiology and Perfusion scanning are his primary areas of study.
The study incorporates disciplines such as Odds ratio, Clinical trial and Perfusion in addition to Stroke.
His Thrombolysis study integrates concerns from other disciplines, such as Reperfusion therapy, Interquartile range, Medical emergency, Emergency medicine and Tissue plasminogen activator.
He usually deals with Cardiology and limits it to topics linked to Ischemic stroke and Endovascular therapy and Ischemia.
His Perfusion scanning research includes themes of Fluid-attenuated inversion recovery, Wake up stroke and Angiography.
His Fibrinolytic agent research is multidisciplinary, incorporating perspectives in Anesthesia and Brain ischemia.
Between 2019 and 2021, his most popular works were:
- Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. (102 citations)
- Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK Part 2 randomized clinical trial (32 citations)
- Melbourne mobile stroke unit and reperfusion therapy: Greater clinical impact of thrombectomy than thrombolysis (10 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Stroke
- Surgery
His primary areas of investigation include Stroke, Thrombolysis, Internal medicine, Cardiology and Fibrinolytic agent.
His Stroke study incorporates themes from Odds ratio, Decision support system and Perfusion.
His Thrombolysis research is multidisciplinary, incorporating elements of Reperfusion therapy, Modified Rankin Scale, Randomized controlled trial and Emergency medicine.
His research in Randomized controlled trial intersects with topics in Relative risk and Placebo.
His work focuses on many connections between Cardiology and other disciplines, such as Interquartile range, that overlap with his field of interest in Thrombus.
Mark W. Parsons combines subjects such as Anesthesia, Brain ischemia and Tenecteplase with his study of Fibrinolytic agent.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
